AHSN Network 6 November 2019
- Physiomics has developed a proprietary model-aided simulation of tumours, Virtual Tumour™. The company wants to expand the utility of this technology by exploring methods of personalising oncology treatments and dosages for patients and has partnered with Oxford AHSN and clinicians at Oxford University Hospitals to explore the utility of the technology in different tumour types, in particular oesophageal cancer and prostate cancer.
